2020-07-28
TALLC Corporation Inc. (TALLC) a pioneering pharmaceutical company using proprietary new molecular entities to treat acute and chronic inflammation announced that the United Kingdom Intellectual Property Office (IPO) has granted TALLC patent GB2561009 entitled “Non-ionic Block Copolymers and Pharmaceutical Compositions Derived Therefrom” the first in a series of SmartCelle smart micelle patents...
